Drugs Affecting the Adrenergic System Flashcards
Oxymetazaline (OTRIVINE) and Phenylephrine (NEO-SYNEPHRINE, SUDAFED PE)
Pharmacodynamics: α1 selective agonist;
Indication for use: treat nasal congestion as well as for eye redness and phenylephrine treats hypotension.
Clonidine (CATAPRES, DURACLON)
Pharmacodynamics: α2 selective agonist;
Indication for use: decrease sympathetic tone and lowers blood pressure, used in ADHD and to reduce withdrawal symptoms.
Dobutamine (DOBUTREX)
Pharmacodynamics: β1 selective agonist;
Indication for use: increase heart rate and cardiac output so treats acute heart failure.
Albuterol (Salbutamol / Ventolin) and Terbutaline
Pharmacodynamics: β2 selective agonist;
Indication for use: causes bronchodilation so used in the treatment of asthma.
Mirabegron (MYRBETRIQ)
Pharmacodynamics: β3 selective agonist;
Indication for use: stimulates β3 on surface of detrusor muscle relieving symptoms of over active bladder.
Clinical features: should not be given with metoprolol as Mirabegron enhances effect of other drugs metabolised in the pathway.
Ephedrine
Pharmacodynamics: Mixed action agonist;
Indication for use: Vasoconstriction and bronchodilation;
Clinical features: Has a long duration as non - catecholamine, is a poor substrate for COMT and MAO.
Pseudoephedrine (SUDAFED)
Pharmacodynamics: Mixed action agonist;
Indication for use: same as ephedrine and activates in nasal passages allowing less fluid to leave and reduces inflammation and mucus production.
Phentolamine (REGITINE)
Pharmacodynamics: non selective α receptor antagonist;
Indication for use: treats hypertension caused by pheochromocytoma (rare tumour of the adrenal gland);
Clinical features: α2 is present on presynaptic nerve ending to inhibit NE release; blockage –> more NE which stimulates Beta – 1 receptor on the heart so can cause tachycardia and arrhythmias.
Phenoxybenzamine (DIBENZYLINE)
Pharmacodynamics: Irreversible non selective α receptor antagonist;
Indication for use: treats hypertension caused by pheochromocytoma (rare tumour of the adrenal gland);
Clinical features: α2 is present on presynaptic nerve ending to inhibit NE release; blockage –> more NE which stimulates Beta – 1 receptor on the heart so can cause tachycardia and arrhythmias.
Prazosin (MINIPRESS), Doxazosin (CARDURA), Terazosin (HYTRIN), Tamsulosin (FLOMAX), Alfuzosin (UROXATRAL) and Silodosin
Pharmacodynamics: Selective α1 blocker;
Indication for use: on vascular smooth muscle which reduces blood pressure and blocks receptors on smooth muscle of bladder neck and prostrate causing smooth muscle to relax leading to relief of urinary issues related to Benign Prostatic Hyperplasia (BPH).
Yohimbine (YOCON)
Pharmacodynamics: selective α2 blocker;
Indication for use: Veterinary drug used to reverse sedation.
Propranalol (INDERAL LA, INNOPRAN XL), Pindolol (VISKEN), Nadolol (CORGARD), Sotalol, Timolol (BETIMOL, ISTALOL, TIMOPTIC)
Pharmacodynamics: β non-selective (1st generation) competitive inhibitor;
Indication for use: decreases heart rate, delayed conduction through the AV node and reduced contractility –> Decreases cardiac output and decreased oxygen demand; Propranolol also penetrate the CNS and is therefore useful for migraine prophylaxis; Nadalol and Timolol when applied to eye decreases IO pressure and treats Glaucoma.
Clinical features: Blocking of β2 in lungs so can lead to bronchoconstriction.
Atenolol (TENORMIN), Acebutalol (SECTRAL), Bisoprolol (ZEBETA), Esmolol (BREVIBLOC), Metoprolol (LOPRESSOR, TOPROL-XL), Betaxalol (BETOPTIC-S, KERLONE)
Pharmacodynamics: β1 selective (second generation) competitive inhibitor;
Indication for use: Similar effects to 1st generation (reduces tachycardia) but more suitable for chronic lung disease such as asthma causing bronchodilation.
Carvedilol (COREG, COREG CR), Labetalol (TRANDATE)
Pharmacodynamics: β1 and α1 blocker (3rd generation);
Indication for use: Cause vasodilation - so used for hypertension and heart failure.
Nebivolol and Betaxalol
Pharmacodynamics: selective β1 blocker (3rd generation);
Indication for use: Used in treatment of hypertension by blocking calcium channels.
What are the common side effects of α1 agonists?
Can cause headache, reflex bradycardia, excitability, and restlessness (cause systemic vasoconstriction); In patients with coronary artery disease can precipitate angina. α1 agonists used as nasal preparation can cause a rebound effect.
What are the common side effects of α2 agonists?
Can cause sedation, dry mouth and nasal mucosa (because of increased vagal activity), bradycardia, orthostatic hypotension, and impotence. Constipation, nausea and gastric upset are also associated with the sympatholytic effects of these drugs. Fluid retention and edema is also a problem with chronic therapy; therefore, concurrent therapy with a diuretic is necessary. Sudden discontinuation of clonidine can lead to rebound hypertension, which results from excessive sympathetic activity.
What are the common side effects of β1 agonists?
Can cause anxiety, hypertension, increased heart rate, and insomnia. Other side effects include headaches and essential tremor. Hypoglycemia was also reported due to increased secretion of insulin.
What are the common side effects of β2 agonists?
Acts centrally and blocks NE re-uptake Tachycardia secondary to peripheral vasodilation and cardiac stimulation; tachycardia can be accompanied by palpitations. Tremor, excessive sweating, anxiety, insomnia, and agitation. More severe effects, such as pulmonary edema, myocardial ischemia, and cardiac arrhythmia.
What type of receptors is beta 2 and what are its effects?
Gs GPCR - lungs, bronchial smooth muscle lead to bronchodilation. Located on vascular smooth muscle and arteries of skeletal muscle – lead to relaxation of blood vessel. Located on smooth muscle of GIT and uterus lead to relaxation (decreased motility and inhibition of labor), found in pancreas and increase insulin secretion.
What are the contraindications for α1 agonists?
Contraindicated in those who suffer from hypertension, bradycardia, prostatic hyperplasia, and anyone using medications, which may also increase blood pressure.
What are the contraindications for α2 agonists?
Contraindicated in anyone who has low blood pressure. Geriatric patients may be at increased risk of falls due to the sedating and hypotensive effects.
What are the contraindications for β1 agonists?
Contraindicated in patients who have arrhythmias.
What are the contraindication for β2 agonists?
Contraindicated in patients who have hypokalemia.